NCT04105920View on ClinicalTrials.gov

Evaluation of the Interest of Hyaluronic Acid in the Preservation of Sexual Function During Prostate Curietherapies

NAActive, not recruitingINTERVENTIONAL
Enrollment

162

Participants

Timeline

Start Date

October 5, 2021

Primary Completion Date

April 5, 2027

Study Completion Date

April 5, 2027

Conditions
Prostate Cancer
Interventions
DEVICE

Hyaluronic acid arm

Patients included in this arm, will have, before insertion of brachytherapy seeds in the prostate, an injection of hyaluronic acid between the prostate, rectum, and pudendal arteries

Trial Locations (3)

21079

Centre Jean François Leclerc, Dijon

38043

Radiothérapie, Hôpital A. Michallon, CHU de Grenoble, Grenoble

69495

Centre Hospitalier Lyon Sud, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER